日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

奥拉帕尼和塞拉塞替(AZD6738)治疗三阴性晚期乳腺癌患者:plasmaMATCH试验E组的结果(CRUK/15/010)

Ring, Alistair; Kilburn, Lucy S; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew M; Gurel, Bora; Macpherson, Iain R; Riisnaes, Ruth; Baird, Richard D; Martin, Sue; Roylance, Rebecca; Johnson, Hannah; Ferreira, Ana; Winter, Matthew C; Dunne, Kathryn; Copson, Ellen; Hickish, Tamas; Burcombe, Russell; Randle, Kat; Serra, Violeta; Llop-Guevara, Alba; Bliss, Judith M; Turner, Nicolas C